Is the light at the end of the tunnel nigh? A review of ADPKD focusing on the burden of disease and tolvaptan as a new treatment

Autosomal dominant polycystic kidney disease (ADPKD) causes pathological cystic changes to the kidney and is characterized by numerous renal and systemic manifestations. ADPKD is the fourth most common renal disease requiring renal replacement therapy. In this report, we present a detailed review of...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnawi, Rashid A, Attar, Rahaf Z, Alfaer, Sultan S, Safdar, Osama Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798550/
https://www.ncbi.nlm.nih.gov/pubmed/29440922
http://dx.doi.org/10.2147/IJNRD.S136359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798550/
https://www.ncbi.nlm.nih.gov/pubmed/29440922
http://dx.doi.org/10.2147/IJNRD.S136359

Ejemplares similares